Peptech (PTD) Buy; Price Target: $1.76; Share Price: $1.27;
Market Cap: $211m.
The antibody space is hot property in the global pharmaceutical
market. Peptech with its 33.6 per cent shareholding in UK based Domantis
is well placed to benefit from this activity.
Domantis earlier this week was the first winner of the UK
innovation in Drug Discovery & Development Award presented in London.